000 02813nam a2200301 4500
001 ESSALUD
005 20260903142646.0
007 ta
008 t pe ||||| |||| 00| 0 spa d
040 _aBMG
041 _aeng
100 _aBernigaud, Charlotte
_eAutor
_954546
245 _aCombined oral ivermectin and 5% permethrin cream to treat severe scabies
300 _apáginas: 1814-1823
520 _aBackground: Severe scabies, a rare parasitic skin disease characterized by abundant skin mites, may be life-threatening and poses public health concerns worldwide. A combination of standard-dose oral ivermectin and topical scabicides is recommended for treatment. However, data from randomized clinical trials are lacking, and the probability of cure is uncertain. Ivermectin at higher doses has been effective in the treatment of some parasitic diseases. Methods: We conducted a blinded randomized trial involving adults with severe scabies (i.e., profuse or crusted), as confirmed by parasitologic or dermoscopic assessment. The patients were assigned in a 1:1 ratio to receive oral ivermectin (to be taken with food) at a dose of 400 μg per kilogram of body weight (higher-dose group) or 200 μg per kilogram (standard-dose group) on days 0, 7, and 14, combined with head-to-toe application of 5% permethrin cream on days 0 and 7 and daily application (as recommended) of an emollient cream. The primary end point was cure of severe scabies, which was defined as the absence of mites and mite-related products (i.e., eggs and feces), as confirmed by parasitologic or dermoscopic assessment on days 18 and 21, and the absence of active clinical lesions on physical examination on day 28. Results: A total of 132 patients (66 in each group) were included in the main analysis. Cure was observed in 75% of the patients in the higher-dose group and in 82% of those in the standard-dose group (odds ratio for cure, 0.64; 95% confidence interval, 0.25 to 1.67). No safety issues were identified. Conclusions: Among adults, the 400-μg-per-kilogram dose of ivermectin plus 5% permethrin cream was not superior to the standard 200-μg-per-kilogram dose of ivermectin plus 5% permethrin cream in curing severe scabies.
650 _aDERMATOLOGÍA GENERAL
_954449
650 _aSALUD GLOBAL
_910472
650 _aENFERMEDADES INFECCIOSAS GENERALES
_954087
650 _aINFECCIONES PARASITARIAS
_954373
700 _aDo-Pham, Giao
_954547
700 _aGuichard, Elie
_954548
700 _aBeylot-Barry, Marie
_954549
700 _aGoujon, Elisa
_954550
700 _aIsnard, Camille
_954551
700 _aBeneton, Nathalie
_954552
773 0 _022717
_922676
_dMassachusetts NEJM Group
_oNEJM015
_tThe New England Journal of Medicine
_wESSALUD
_x0028-4793
942 _cARTICULOS
_e2026-08-31
_zsqb
999 _c22926
_d22926